ZELFIX-CV 625
VITALIZE THE HEALTH BY COUNTERACTING FREE RADICAL DAMAGE
Cefuroxime 500mg + Clavulnate Potassium 125mg.
CEFUROXIME
- Active against several gram-positive and gram-negative organisms.
- Achieves clinical success by 93.4% in treatment of Respiratory Tract Infections.
CLAVULANATE POTASSIUM:
- Potent beta-lactamase inhibitor.
- In combination, it extends the antibacterial activity of cefuroxime to include beta
lactamase-producing strains. - PHARYNGITIS/TONSILLITIS I ACUTE BACTERIAL OTITIS MEDIA ACUTE BACTERIAL MAXILLARY SINUSITIS ACUTE BACTERIAL EXACERBATIONS OF CHRONIC BRONCHITIS UNCOMPLICATED URINARY TRACT INFECTIONS UNCOMLPLICATED GONORRHEA.